Immuno-Imaging to Predict Treatment Response in Infection, Inflammation and Oncology.

ABSTRACT: Molecular nuclear medicine plays a pivotal role for diagnosis in a preclinical phase, in genetically susceptible patients, for radio-guided surgery, for disease relapse evaluation, and for therapy decision-making and follow-up. This is possible thanks to the development of new radiopharmaceuticals to target specific biomarkers of infection, inflammation and tumour immunology. In this review, we describe the use of specific radiopharmaceuticals for infectious and inflammatory diseases with the aim of fast and accurate diagnosis and treatment follow-up. Furthermore, we focus on specific oncological indications with an emphasis on tumour immunology and visualizing the tumour environment. Molecular nuclear medicine imaging techniques get a foothold in the diagnosis of a variety of infectious a

SUBMITTER: Signore A 

PROVIDER: S-EPMC6571748 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature